A study published on December 13, 2013 in the Journal of Women’s Health found that “there was a higher frequency of lab-positive findings of HSV (genital herpes) and self-reported history of genital warts for women veterans compared to non-veterans (1).” polyDNA urges healthcare providers to recommend Gene-Eden-VIR, an HPV and HSV remedy, to improve women veterans’ reproductive health.
Rochester, NY (PRWEB) December 26, 2013
polyDNA has learned that U.S. women military veterans have a higher rate of genital herpes (HSV-2) and genital warts (HPV) than active duty and civilian women (1). Study authors wrote that “In particular, women veterans were more likely to test positive for HSV-2, with almost 40% of veterans testing positive compared to 26% of (active duty) non-veterans. This rate is particularly high, as a recent report using NHANES data from 2005–2008 suggested that the seropositive rate among women (in the general population) was 20% (1).” In addition, “Women veterans were also more likely than non-veterans to report a history of genital warts (1).” polyDNA recommends Gene-Eden-VIR to help the immune system of service women target the latent HSV and HPV.
Researchers discovered that one reason for the high rates of genital herpes and genital warts was high risk sexual behavior. Some of these behaviors include a “increasing number of sexual partners, and younger age of sexual activity initiation (1).” The authors wrote that “previous research suggests that women veterans report more frequent childhood abuse and adult sexual assault than non-veterans, and abuse has been associated with adult sexual risk behaviors in the general population. Moreover, combat exposure has been associated with increased risk taking, which may also include engaging in high risk sexual behaviors. Finally, compared with non-veterans, women veterans have higher rates of mental health conditions, including depression and post-traumatic stress disorder, which may play an intermediate role in explaining their higher rates of certain sexual behaviors (1).”
Another study published on November 21, 2012 in the Journal of Women’s Health found the following alarming statistics:· The rates of sexually transmitted infections (STIs) are seven times higher for military women than civilian women (2).
· Only 33% of sexually active unmarried active duty military women reported using condoms during last intercourse (2).
· Nearly 60% reported having more than one sexual partner within the last year. A separate study revealed that 27% of servicewomen surveyed reported more than one partner in the previous 90 days. In that group, only 17% reported that her partner always wore a condom (2).
In a survey of Army recruits, 33% of female respondents reported binge drinking in the previous month, as compared with 6 to 7% of women in the general US population. Binge drinking is associated with unsafe sexual practices and unwanted sexual activity among female military personnel (2).
What does this mean for female military veterans, active duty service women, and their healthcare providers?
For those women that engage in risky sexual behavior, infection with the genital herpes (HSV-2) or genital warts (HPV), or both is a high probability. Under these conditions, polyDNA recommends Gene-Eden-VIR to help their immune systems target the latent form of herpes and HPV.
polyDNA urges healthcare providers to be more attuned to the reproductive healthcare of females in the service and female military veterans that may already be infected with genital herpes or HPV. One way healthcare providers can do that is by recommending Gene-Eden-VIR to military service women and veterans.
In addition, female military veterans and active duty personnel can learn more about Gene-Eden-VIR by searching online.
A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced HPV and HSV symptoms. Study authors wrote that, “Individuals infected with the HPV and/or HSV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (3).” The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (3).”
To learn more about Gene-Eden-VIR, and HPV visit http://www.gene-eden-kill-virus.com. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
References:
(1) Sexual Behaviors and Sexually Transmitted Infections in a Nationally Representative Sample of Women Veterans and Nonveterans. Published on December 13, 2013.
http://www.ncbi.nlm.nih.gov/pubmed/24328438
(2) High-risk behavior and sexually transmitted infections among U.S. active duty servicewomen and veterans. Published on November 21, 2012.
http://www.ncbi.nlm.nih.gov/pubmed/22994983
(3) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013.
http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses. Reported by PRWeb 12 hours ago.
Rochester, NY (PRWEB) December 26, 2013
polyDNA has learned that U.S. women military veterans have a higher rate of genital herpes (HSV-2) and genital warts (HPV) than active duty and civilian women (1). Study authors wrote that “In particular, women veterans were more likely to test positive for HSV-2, with almost 40% of veterans testing positive compared to 26% of (active duty) non-veterans. This rate is particularly high, as a recent report using NHANES data from 2005–2008 suggested that the seropositive rate among women (in the general population) was 20% (1).” In addition, “Women veterans were also more likely than non-veterans to report a history of genital warts (1).” polyDNA recommends Gene-Eden-VIR to help the immune system of service women target the latent HSV and HPV.
Researchers discovered that one reason for the high rates of genital herpes and genital warts was high risk sexual behavior. Some of these behaviors include a “increasing number of sexual partners, and younger age of sexual activity initiation (1).” The authors wrote that “previous research suggests that women veterans report more frequent childhood abuse and adult sexual assault than non-veterans, and abuse has been associated with adult sexual risk behaviors in the general population. Moreover, combat exposure has been associated with increased risk taking, which may also include engaging in high risk sexual behaviors. Finally, compared with non-veterans, women veterans have higher rates of mental health conditions, including depression and post-traumatic stress disorder, which may play an intermediate role in explaining their higher rates of certain sexual behaviors (1).”
Another study published on November 21, 2012 in the Journal of Women’s Health found the following alarming statistics:· The rates of sexually transmitted infections (STIs) are seven times higher for military women than civilian women (2).
· Only 33% of sexually active unmarried active duty military women reported using condoms during last intercourse (2).
· Nearly 60% reported having more than one sexual partner within the last year. A separate study revealed that 27% of servicewomen surveyed reported more than one partner in the previous 90 days. In that group, only 17% reported that her partner always wore a condom (2).
In a survey of Army recruits, 33% of female respondents reported binge drinking in the previous month, as compared with 6 to 7% of women in the general US population. Binge drinking is associated with unsafe sexual practices and unwanted sexual activity among female military personnel (2).
What does this mean for female military veterans, active duty service women, and their healthcare providers?
For those women that engage in risky sexual behavior, infection with the genital herpes (HSV-2) or genital warts (HPV), or both is a high probability. Under these conditions, polyDNA recommends Gene-Eden-VIR to help their immune systems target the latent form of herpes and HPV.
polyDNA urges healthcare providers to be more attuned to the reproductive healthcare of females in the service and female military veterans that may already be infected with genital herpes or HPV. One way healthcare providers can do that is by recommending Gene-Eden-VIR to military service women and veterans.
In addition, female military veterans and active duty personnel can learn more about Gene-Eden-VIR by searching online.
A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced HPV and HSV symptoms. Study authors wrote that, “Individuals infected with the HPV and/or HSV…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR (3).” The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (3).”
To learn more about Gene-Eden-VIR, and HPV visit http://www.gene-eden-kill-virus.com. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
References:
(1) Sexual Behaviors and Sexually Transmitted Infections in a Nationally Representative Sample of Women Veterans and Nonveterans. Published on December 13, 2013.
http://www.ncbi.nlm.nih.gov/pubmed/24328438
(2) High-risk behavior and sexually transmitted infections among U.S. active duty servicewomen and veterans. Published on November 21, 2012.
http://www.ncbi.nlm.nih.gov/pubmed/22994983
(3) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013.
http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses. Reported by PRWeb 12 hours ago.